Intrinsic resistance to <scp>ROS1</scp> inhibition in a patient with <scp><i>CD74‐ROS1</i></scp> mediated by <scp>AXL</scp> overexpression
Tara L. Peters(University of Colorado Anschutz Medical Campus), Robert C. Doebele(University of Colorado Anschutz Medical Campus)
Cited by 2
Related Papers
An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer
|Journal of Thoracic Oncology|2016|81
Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLC
|npj Precision Oncology|2021|11